<div id="readability-page-1"><div> <div> , /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charming Medical Limited (&#34;Charming&#34; or &#34;the Company&#34;) (NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 21, 2025, and November 12, 2025, inclusive (the &#34;Class Period&#34;), are encouraged to contact the firm before February 17, 2026. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected]. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Charming was the subject of an SEC trading suspension in November 2025 after its shares spiked in price dramatically despite no news from the Company justifying its rapid increase. The suspension was based on allegations that the Company's shares were the subject of a promotion scheme involving supposed financial advisors touting the Company on social media and related forums. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Charming, investors suffered damages. Join the case to recover your losses The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. CONTACT: The Schall Law Firm Brian Schall, Esq., www.schallfirm.com Office: 310-301-3335 [email protected] SOURCE The Schall Law Firm <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjAyJk5ld3NJdGVtSWQ9TEE3NjA3OCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDIwNDE5UFJfTkVXU19VU1BSX19fX19MQTc2MDc4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjAyJk5ld3NJdGVtSWQ9TEE3NjA3OCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDIwNDE5UFJfTkVXU19VU1BSX19fX19MQTc2MDc4"/></div> </div></div>

MCTA

The Schall Law Firm is reminding investors of a class action lawsuit against Charming Medical Limited (NASDAQ: MCTA) for alleged securities fraud. The lawsuit claims violations of the Securities Exchange Act due to false statements made by the company during the class period from October 21, 2025, to November 12, 2025. Investors who suffered losses are encouraged to contact the firm before February 17, 2026, to discuss their rights. The company faced an SEC trading suspension in November 2025 amid allegations of a promotion scheme that misled investors.

prnewswire

Charming Medical

iShares Global Healthcare

04:19 ET MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm